APA

Zeydan B., Uygunoglu U., Saip S., Demirci O. N., Seyahi E., Ugurlu S., Hamuryudan V., Siva A. & Kantarci O. H. (20160726). Infliximab is a plausible alternative for neurologic complications of Behçet disease. : Neurology(R) neuroimmunology & neuroinflammation.

Chicago

Zeydan Burcu, Uygunoglu Ugur, Saip Sabahattin, Demirci Onat N, Seyahi Emire, Ugurlu Serdal, Hamuryudan Vedat, Siva Aksel and Kantarci Orhun H. 20160726. Infliximab is a plausible alternative for neurologic complications of Behçet disease. : Neurology(R) neuroimmunology & neuroinflammation.

Harvard

Zeydan B., Uygunoglu U., Saip S., Demirci O. N., Seyahi E., Ugurlu S., Hamuryudan V., Siva A. and Kantarci O. H. (20160726). Infliximab is a plausible alternative for neurologic complications of Behçet disease. : Neurology(R) neuroimmunology & neuroinflammation.

MLA

Zeydan Burcu, Uygunoglu Ugur, Saip Sabahattin, Demirci Onat N, Seyahi Emire, Ugurlu Serdal, Hamuryudan Vedat, Siva Aksel and Kantarci Orhun H. Infliximab is a plausible alternative for neurologic complications of Behçet disease. : Neurology(R) neuroimmunology & neuroinflammation. 20160726.